We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.8B
AUM Growth
+$319M
Cap. Flow
-$1.05B
Cap. Flow %
-4.6%
Top 10 Hldgs %
12.97%
Holding
1,455
New
91
Increased
461
Reduced
477
Closed
261

Top Buys

Rank Stock Value
1
NBL
Noble Energy, Inc.
NBL
+$59.9M
2
NVDA icon
NVIDIA
NVDA
+$57.7M
3
CSX icon
CSX Corp
CSX
+$56M
4
TRV icon
Travelers Companies
TRV
+$54.1M
5
GM icon
General Motors
GM
+$48.9M

Top Sells

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$85.8M
2
CAG icon
Conagra Brands
CAG
+$71.5M
3
TSCO icon
Tractor Supply
TSCO
+$51.7M
4
HCA icon
HCA Healthcare
HCA
+$49.7M
5
ABT icon
Abbott
ABT
+$43.9M

Sector Composition

Rank Sector Weight
1 Healthcare 17.71%
2 Technology 14.64%
3 Financials 10.48%
4 Industrials 9.99%
5 Consumer Discretionary 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNTA
776
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.67M 0.01%
+142,681
New +$1.68M
MCS icon
777
Marcus Corp
MCS
$849M
$1.67M 0.01%
66,480
+33,480
+101% +$767K
CCF
778
DELISTED
Chase Corporation
CCF
$1.66M 0.01%
24,030
+15,817
+193% +$986K
DDC
779
DELISTED
Dominion Diamond Corporation
DDC
$1.66M 0.01%
170,116
+3,600
+2% +$32.3K
LEA icon
780
Lear
LEA
$6.22B
$1.65M 0.01%
13,600
-800
-6% -$91.1K
IVZ icon
781
Invesco
IVZ
$13.6B
$1.64M 0.01%
52,500
+29,500
+128% +$867K
SRI icon
782
Stoneridge
SRI
$204M
$1.64M 0.01%
89,000
+20,200
+29% +$348K
KSS icon
783
Kohl's
KSS
$1.88B
$1.63M 0.01%
+37,300
New +$1.56M
OME
784
DELISTED
Omega Protein
OME
$1.63M 0.01%
69,600
-3,500
-5% -$82.2K
XOXO
785
DELISTED
Xo Group Inc
XOXO
$1.62M 0.01%
83,900
-2,300
-3% -$42.4K
IEMG icon
786
iShares Core MSCI Emerging Markets ETF
IEMG
$160B
$1.61M 0.01%
35,400
AAL icon
787
American Airlines Group
AAL
$8.52B
$1.58M 0.01%
43,068
+11,624
+37% +$411K
VRN
788
DELISTED
Veren
VRN
$1.58M 0.01%
119,410
+92,270
+340% +$1.38M
GFF icon
789
Griffon
GFF
$4.27B
$1.57M 0.01%
92,220
IMPV
790
DELISTED
Imperva, Inc.
IMPV
$1.56M 0.01%
29,000
-52,000
-64% -$2.41M
ALL icon
791
Allstate
ALL
$65.1B
$1.56M 0.01%
22,500
+1,900
+9% +$131K
WBD icon
792
Warner Bros
WBD
$70.2B
$1.55M 0.01%
57,500
+18,800
+49% +$482K
MAS icon
793
Masco
MAS
$13.6B
$1.52M 0.01%
44,317
CTS icon
794
CTS Corp
CTS
$1.66B
$1.52M 0.01%
81,621
+77,521
+1,891% +$1.46M
EIS icon
795
iShares MSCI Israel ETF
EIS
$906M
$1.51M 0.01%
31,500
DHC
796
Diversified Healthcare Trust
DHC
$1.93B
$1.51M 0.01%
66,600
-1,072,644
-94% -$23.7M
PACB icon
797
Pacific Biosciences
PACB
$429M
$1.49M 0.01%
165,900
-6,400
-4% -$53.5K
AFSI
798
DELISTED
AmTrust Financial Services, Inc.
AFSI
$1.47M 0.01%
54,900
-156,486
-74% -$4.02M
RDUS
799
DELISTED
Radius Health, Inc.
RDUS
$1.46M 0.01%
+26,891
New +$1.37M
EWK icon
800
iShares MSCI Belgium ETF
EWK
$166M
$1.45M 0.01%
77,097
-8,600
-10% -$156K

Similar funds

Axa's Q3 2016 Portfolio in Review

As of Q3 2016, Axa held 1,455 positions worth $22.8B, up 1.4% from $22.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Axa withdrew a net $1.05B in Q3 2016, closing 261 positions and reducing 477 holdings. Its most notable exit was Dentsply Sirona, an estimated $24.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

Against the trend, Axa opened a new position in Juniper Networks worth $13.6M.

  • Axa's largest Q3 2016 buy was Juniper Networks: 566,920 shares worth $13.6M.
  • Axa added most to Noble Energy, Inc. in Q3 2016, an estimated $59.9M increase.
  • Axa's biggest Q3 2016 reduction was Johnson Controls International, cutting an estimated $85.8M.
  • Axa fully exited Dentsply Sirona in Q3 2016, selling an estimated $24.4M.
  • Axa's ten largest holdings make up 13% of its $22.8B portfolio in Q3 2016.
  • Axa opened 91 new positions and closed 261 in Q3 2016.
  • Axa's portfolio value rose 1.4% quarter-over-quarter to $22.8B.

Based on Axa's 13F filing for Q3 2016, filed 10 Nov 2016.